Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 50,500 shares, an increase of 136.0% from the November 15th total of 21,400 shares. Based on an average trading volume of 67,300 shares, the short-interest ratio is currently 0.8 days. Approximately 0.7% of the shares of the stock are sold short.

Sol-Gel Technologies Price Performance

Shares of SLGL opened at $0.51 on Thursday. Sol-Gel Technologies has a 1-year low of $0.33 and a 1-year high of $1.58. The stock has a market cap of $14.23 million, a price-to-earnings ratio of -1.50 and a beta of 1.62. The firm has a 50 day simple moving average of $0.58 and a 200-day simple moving average of $0.65.

Wall Street Analyst Weigh In

Separately, Raymond James cut Sol-Gel Technologies from a “strong-buy” rating to an “outperform” rating and lowered their price target for the stock from $6.00 to $4.00 in a report on Monday, August 19th.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.